Top ASX Dividend Stocks: Korvest, Sugar Terminals, and Steadfast Group Lead the Way

Korvest is a stable dividend stock with a 5% yield, covered by earnings and cash flows. Despite past volatility, Korvest has seen significant earnings growth, with a final dividend of A$0.40 and a special dividend of A$0.10 payable on September 5, 2025. QBE Insurance Group offers a 3.7% dividend yield and has a strong presence in general insurance and reinsurance across various regions.

Realty Income, Healthpeak Properties, and Pfizer are three prominent stocks offering high-yield dividends, each with unique attributes and growth prospects. Despite the challenges posed by recent market conditions and interest rate fluctuations, these stocks continue to provide attractive income opportunities for investors seeking long-term growth.

Realty Income (NYSE: O), a net lease real estate investment trust (REIT), has been a reliable dividend grower with a consistent monthly payout for over 30 years. Despite a 22% drop from its 2022 peak, Realty Income offers a 5.5% dividend yield [1]. The company's portfolio of 15,606 properties provides a diversified revenue stream, and its cash flows have grown steadily despite rising interest rates. Realty Income's addressable market in the U.S. is relatively small, but it has been expanding its European presence, where demand for its services is high.

Healthpeak Properties (NYSE: DOC), a healthcare REIT specializing in laboratory space, has seen a decline in demand from biotech start-ups but has offset this with a merger with Physicians Realty. The resulting stock offers a 6.8% dividend yield [1]. Healthpeak's portfolio of 255 properties is focused on life sciences and healthcare facilities, providing stable rental income. The company expects funds from operations (FFO) to support its current payout of $1.22 per share [1].

Pfizer (NYSE: PFE), a global biopharmaceutical company, has faced challenges due to declining COVID-19 product sales and upcoming patent cliffs. However, the company has maintained its 6.9% dividend yield [1] and has raised its dividend for 16 consecutive years. Pfizer's strong cash flows and consistent earnings growth support its attractive dividend yield, making it a solid choice for long-term investors.

Investors should consider their individual financial circumstances and conduct thorough research before making investment decisions. These high-yield dividend stocks offer unique opportunities for income-focused investors seeking consistent dividend growth and strong cash flows.

References:
[1] https://finance.yahoo.com/news/3-high-yield-dividend-stocks-072100143.html